• Title/Summary/Keyword: Bryonia alba L.

Search Result 3, Processing Time 0.018 seconds

Bryonia alba and Its Biochemical, Pharmacological Actions and Toxicity

  • Lee, Dong Wook;Aprikian, G.V.;Sohn, Hyung-Ok
    • Journal of the Korean Society of Tobacco Science
    • /
    • v.35 no.1
    • /
    • pp.56-61
    • /
    • 2013
  • Bryonia alba L. belongs to the Cucurbitaceae family and grows in Europe, Asia, America, Africa, Russia, Ukraina and Armenia. The root of Bryonia alba has been used for neuropsychical diseases, psychosis, hysteria, paralysis, epilepsy, vertigo, headache, migrain, melancholia, forgetfulness, sadness, absent mindedness, delirium, cardiovascular disease, ischemia, gastrointestinal diseases, gastric ulcer and respiratory diseases. The root of Bryonia alba contains an oxidized tetra cyclic triterpens, cucurbitaceous, polyunsaturated hydrocarbons, phospholipids, phosphatidylcholines, ethereal oils, fatty acids, a great amount of amino acids, alcohol soluble enzymes, sugar, carotene, vitamin C and E. Bryonia alba increases coronary blood-flow and the amplitude of cardiac contractions. Bryonia alba has an antistressor action and increases the working capacity. Bryonia alba activates connective tissue cells. Bryonia alba markedly increases the oxygen consumption by young and senescent rat brain, liver as well as heart mitochondrial fraction as Korean Ginseng. Bryonia alba decreases lipid peroxidation after immobilization stress. In conclusion, Bryonia alba like Ginseng used in traditional medicine came from ancient time has a good perspective administration as prophylactic and medical remedy, as remedy of lot of diseases in modern medicine.

Cytotoxic Constituents from the Roots of Bryonia alba L.

  • Baek, Nam-In;Lee, Dong-Wook;Lee, You-Hui;Kim, Shin-Il;Aprikian, Goorgen V.
    • Natural Product Sciences
    • /
    • v.1 no.1
    • /
    • pp.43-49
    • /
    • 1995
  • Two cucurbitane-compounds were isolated from the roots of Bryonia alba L. and the chemical structures were established as 19-norlanost-5-ene-3,1l,22-trione-$2{\beta}$, $16{\alpha}$,$20{\beta}$,25-tetrahydroxy-9-methyl (23,24-dihydrocucurbitacin D) and 2-O-${\alpha}$-D-glucopyranosyl 19-norlanost-5-ene-3,11,22-trione-$2{\beta}$,$16{\alpha}$,$20{\beta}$,25-tetrahydroxy-9-methyl (arvenin IV), respectively, on the basis of chemical and spectral methods. Both of the compounds showed cytotoxic activity against cancer cell lines, A549, SK-MEL-2, COLO 205 and L1210.

  • PDF

Antitumor Activity of 23, 24-dihydrocucurbitacin D Isolated from Bryonia alba L.

  • Sohn, Hyung-Ok;Lee, Young-Gu;Lim, Heung-Bin;Kwon, Nyoun-Soo;Goorgen V. Aprikian;Lee, Dong-Wook
    • Toxicological Research
    • /
    • v.16 no.4
    • /
    • pp.263-267
    • /
    • 2000
  • The cytotoxic and antitumor activity of 23,24-dihydrocucurbitacin D (dhc D) isolated from Bryonia alba L. was examined. Our results showed that dhc D strongly inhibited the viability of the cultured cancer cells, A-549, COLO 205, SK-MEL-2, and L121O. It also exhibited effective antitumor activity in ICR mice, which had been intra peritoneally implanted with sarcoma 180 ascites tumor cells. The dhc D also strongly inhibited the viability of immortalized macrophages RAW 264.7, but not normal peritoneal macrophages. These results indicate that dhc D has antiproliferative effect on cancer cells and it may more sensitive on immortalized cells than normal cells.

  • PDF